AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,965,306 | -40.7% | 939,646 | -56.4% | 0.01% | -42.9% |
| Q2 2023 | $6,684,350 | +59.7% | 2,156,242 | -28.4% | 0.01% | +55.6% |
| Q1 2023 | $4,185,154 | -1.6% | 3,010,902 | +40.9% | 0.01% | -10.0% |
| Q4 2022 | $4,251,141 | +116.5% | 2,136,252 | +119.7% | 0.01% | +100.0% |
| Q3 2022 | $1,964,000 | +111.2% | 972,161 | +232.5% | 0.01% | +150.0% |
| Q2 2022 | $930,000 | -5.9% | 292,337 | +23.3% | 0.00% | 0.0% |
| Q1 2022 | $988,000 | +46.8% | 236,998 | +477.5% | 0.00% | +100.0% |
| Q2 2018 | $673,000 | – | 41,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |